Nektar Therapeutics
NKTR
#5817
Rank
HK$8.43 B
Marketcap
HK$414.59
Share price
-2.56%
Change (1 day)
255.48%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$62.22

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$61.99. In 2024 the company made an earnings per share (EPS) of -HK$68.92 an increase over its 2023 EPS that were of -HK$170.35.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$62.22-9.72%
2024-HK$68.92-59.54%
2023-HK$170.35-25.89%
2022-HK$229.85-31.12%
2021-HK$333.7014.86%
2020-HK$290.53-1.19%
2019-HK$294.03-163.96%
2018HK$459.71-725.4%
2017-HK$73.51-42.73%
2016-HK$128.3583.33%
2015-HK$70.0139.53%
2014-HK$50.17-69.29%
2013-HK$163.35-6.67%
2012-HK$175.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$101.35-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.07-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
HK$0.07779-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.61-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-HK$5.13-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.10-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
HK$81.20-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA